35788257Larkin KT, Nicolet D, Kelly BJ, Mrózek K, LaHaye S, Miller KE, Wijeratne S, Wheeler G, Kohlschmidt J, Blachly JS, Mims AS, Walker CJ, Oakes CC, Orwick S, Boateng I, Buss J, Heyrosa A, Desai H, Carroll AJ, Blum W, Powell BL, Kolitz JE, Moore JO, Mayer RJ, Larson RA, Stone RM, Paskett ED, Byrd JC, Mardis ER, Eisfeld AKBlood advancesBlack People; Leukemia, Myeloid, AcuteAdolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytogenetics; Drug Resistance, Neoplasm; Humans; Proto-Oncogene Proteins p21(ras); Remission Induction; Young AdultHigh early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML. Blood Adv. 2022 10 11; 6(19):5570-5581.Blood Adv2022-10-11T00:00:002022High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000293Living Beings111389680.400538AdolescentD000328Living Beings1578255770.254432AdultD000971Procedures30624340.476235Antineoplastic Combined Chemotherapy ProtocolsD003582Occupations17270.992505CytogeneticsD006801Living Beings2262862810.130052HumansD019008Physiology1805890.751116Drug Resistance, NeoplasmMedicine-Hematology and OncologyD015470Disorders1227550.629242Leukemia, Myeloid, AcuteAuthorship 155904240.2259070.2259071authors10.2510has subject areaD016283Chemicals & Drugs801530.911453Proto-Oncogene Proteins p21(ras)D012074Procedures1657220.853019Remission InductionD055815Living Beings97159610.423207Young AdultUniversity of ChicagoRichard A.LarsonRichard A. Larson41.78927490000000-87.601250000000001169Larson, Richard A.Professortrue1ProfessorProfessor